Joe Zhou

Mr. Zhou joined Legend Capital in 2010 as Associate, and was later promoted to Vice President, Director, and Executive Director. He is now Managing Director of the firm and focuses on healthcare investments.

Joe led healthcare investments including Axonics (NASDAQ:AXNX), Reach Surgical, Bonovo, Aohua, Zhuhai DL, Access Medical, JenaValve, Cardea, Young Education.

Prior to Legend Capital, Joe worked at Morningside Ventures, Blueprint Co., Ltd., etc.

Joe holds a Bachelor in Biology from University of Science and Technology of China, a Master in Neuroscience from National University of Singapore, and a MBA from China Europe International Business School.